Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

VKTX Viking Therapeutics Inc

67,10

-1,96 (-2,84%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Viking Therapeutics (NASDAQ:VKTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Viking Therapeutics Charts.

Viking Therapeutics (NASDAQ:VKTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Viking Therapeutics Charts.

News Viking Therapeutics Inc

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mittwoch 24 April 2024 (3 Wochen vor) • PR Newswire (US)

U.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures Trading
Mittwoch 24 April 2024 (3 Wochen vor) • IH Market News

Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
Mittwoch 17 April 2024 (1 Monat vor) • PR Newswire (US)

Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
Dienstag 26 März 2024 (2 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Montag 4 März 2024 (2 Monate vor) • PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 1 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
Donnerstag 29 Februar 2024 (3 Monate vor) • PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Viking Therapeutics Announces Proposed Public Offering of Common Stock
Dienstag 27 Februar 2024 (3 Monate vor) • PR Newswire (US)

Weitere Viking Therapeutics Inc News-Artikel

Sparebanken Ost

Global Oceanic Carriers

Canaccord Genuity

Star Peak Corp II

DJ Commodity Index North...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen